BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12139465)

  • 1. Design, synthesis, and biological evaluation of indolequinone phosphoramidate prodrugs targeted to DT-diaphorase.
    Hernick M; Flader C; Borch RF
    J Med Chem; 2002 Aug; 45(16):3540-8. PubMed ID: 12139465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of novel quinone phosphorodiamidate prodrugs targeted to DT-diaphorase.
    Flader C; Liu J; Borch RF
    J Med Chem; 2000 Aug; 43(16):3157-67. PubMed ID: 10956224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of pteroic acid-conjugated nitroheterocyclic phosphoramidates as folate receptor-targeted alkylating agents.
    Steinberg G; Borch RF
    J Med Chem; 2001 Jan; 44(1):69-73. PubMed ID: 11141089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulfonyl-containing aldophosphamide analogues as novel anticancer prodrugs targeted against cyclophosphamide-resistant tumor cell lines.
    Jain M; Fan J; Baturay NZ; Kwon CH
    J Med Chem; 2004 Jul; 47(15):3843-52. PubMed ID: 15239662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and evaluation of targeted hypoxia-activated prodrugs applied to chondrosarcoma chemotherapy.
    Gerard Y; Voissière A; Peyrode C; Galmier MJ; Maubert E; Ghedira D; Tarrit S; Gaumet V; Canitrot D; Miot-Noirault E; Chezal JM; Weber V
    Bioorg Chem; 2020 May; 98():103747. PubMed ID: 32208207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of peptide conjugates of phosphoramide mustard as prodrugs activated by prostate-specific antigen.
    Wu X; Hu L
    Bioorg Med Chem; 2016 Jun; 24(12):2697-706. PubMed ID: 27156193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and biological evaluation of cyclic and acyclic nitrobenzylphosphoramide mustards for E. coli nitroreductase activation.
    Jiang Y; Han J; Yu C; Vass SO; Searle PF; Browne P; Knox RJ; Hu L
    J Med Chem; 2006 Jul; 49(14):4333-43. PubMed ID: 16821793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and biological evaluation of NAD(P)H: Quinone oxidoreductase (NQO1)-targeted oridonin prodrugs possessing indolequinone moiety for hypoxia-selective activation.
    Xu S; Yao H; Pei L; Hu M; Li D; Qiu Y; Wang G; Wu L; Yao H; Zhu Z; Xu J
    Eur J Med Chem; 2017 May; 132():310-321. PubMed ID: 28395199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acyloxymethyl esters of isophosphoramide mustard as new anticancer prodrugs.
    Cytarska J; Misiura K; Filip-Psurska B; Wietrzyk J
    Acta Pol Pharm; 2013; 70(3):481-7. PubMed ID: 23757939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of novel androgen-linked phosphoramide mustard prodrugs and growth-inhibitory activity in human breast cancer cells.
    Roth T; Tang W; Eisenbrand G
    Anticancer Drug Des; 1995 Dec; 10(8):655-66. PubMed ID: 8595124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
    Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A
    Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phthalimide analogs of CB 1954: synthesis and bioactivation.
    Mehta LK; Hobbs S; Chen S; Knox RJ; Parrick J
    Anticancer Drugs; 1999 Sep; 10(8):777-83. PubMed ID: 10573210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotinamide adenine dinucleotide (phosphate): quinone oxidoreductase (DT-diaphorase) as a target for bioreductive antitumor quinones: quinone cytotoxicity and selectivity in human lung and breast cancer cell lines.
    Beall HD; Murphy AM; Siegel D; Hargreaves RH; Butler J; Ross D
    Mol Pharmacol; 1995 Sep; 48(3):499-504. PubMed ID: 7565631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aldophosphamide acetal diacetate and structural analogues: synthesis and cytotoxicity studies.
    Wang YQ; Farquhar D
    J Med Chem; 1991 Jan; 34(1):197-203. PubMed ID: 1992116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. INDQ/NO, a bioreductively activated nitric oxide prodrug.
    Sharma K; Iyer A; Sengupta K; Chakrapani H
    Org Lett; 2013 Jun; 15(11):2636-9. PubMed ID: 23659457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemically stable, lipophilic prodrugs of phosphoramide mustard as potential anticancer agents.
    Kwon CH; Moon KY; Baturay N; Shirota FN
    J Med Chem; 1991 Feb; 34(2):588-92. PubMed ID: 1995881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and biological evaluation of quinazoline-phosphoramidate mustard conjugates as anticancer drugs.
    Lin S; Li Y; Zheng Y; Luo L; Sun Q; Ge Z; Cheng T; Li R
    Eur J Med Chem; 2017 Feb; 127():442-458. PubMed ID: 28092860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the mechanisms of activation of indolequinone phosphoramidate prodrugs.
    Hernick M; Borch RF
    J Med Chem; 2003 Jan; 46(1):148-54. PubMed ID: 12502368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationships for DT-diaphorase reduction of hypoxic cell directed agents: indoloquinones and diaziridinyl benzoquinones.
    Bailey SM; Suggett N; Walton MI; Workman P
    Int J Radiat Oncol Biol Phys; 1992; 22(4):649-53. PubMed ID: 1544832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological studies of novel nucleoside phosphoramidate prodrugs.
    Tobias SC; Borch RF
    J Med Chem; 2001 Dec; 44(25):4475-80. PubMed ID: 11728193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.